**Funding Information**

No funding information provided.

Introduction {#ams2517-sec-0004}
============

Consciousness disorder is a symptom frequently encountered in the emergency department; however, it is difficult to diagnose this condition in the acute phase. Herein, we describe a case of a patient with progressive consciousness impairment and deep coma who was finally diagnosed with Bickerstaff's brainstem encephalitis (BBE). We also found that the auditory brainstem response (ABR) is helpful in detecting lesions and predicting functional recovery.

Case Report {#ams2517-sec-0005}
===========

A 75‐year‐old woman presented with dizziness and weakness in both arms 1 week after an upper respiratory infection. She was transferred to the emergency department due to difficulty in moving. Her medical history showed that she had breast cancer. Magnetic resonance imaging (MRI) did not reveal any intracranial lesions. Examination of her blood sample and cerebrospinal fluid (CSF) also did not show any abnormalities that caused her symptoms. She was admitted to the hospital for further evaluation. She experienced gradual worsening of consciousness after admission, and on the 6th hospital day, Glasgow Coma Scale E1V1M4, dilated pupils, loss of light reflex, and escape of only both upper limbs were observed; therefore, no reaction was observed in both lower limbs. Tracheal intubation was carried out, followed by ventilator management. A second MRI examination also revealed no significant findings on fluid‐attenuated inversion recovery and diffusion‐weighted imaging. The CSF showed a cell count of 6/µL and a total protein content of 39 mg/dL. Electroencephalogram (EEG) occasionally revealed a slow wave of 2--3 Hz. The ABR demonstrated a low voltage, but there was no prolonged interval of latency between I and V wave (Fig. [1](#ams2517-fig-0001){ref-type="fig"}). The somatosensory evoked potential showed bilateral N20. Based on these neurological findings, we supposed the lesion for this neurological deficit was located at the upper part of the brainstem, including the midbrain. On the 10th hospital day, the patient was able to respond to easy verbal commands, and her paralysis was slightly improved. She was considered to be more likely to have Guillain‐Barré syndrome (GBS) or its related disorders, and steroid pulse therapy (1 g/day for 3 days) was initiated. On the 15th hospital day, we noticed left vocal cord paralysis, for which we undertook tracheostomy. The patient's consciousness recovered, and on the 20th day she was transferred for rehabilitation. At a later date, she showed a positive result for serum immunoglobulin G (IgG)‐type GQ1b antibody; on this basis, we made a diagnosis of BBE. After rehabilitation, the patient was discharged home on the 103rd hospital day without any particular neurological sequelae.

![Waveform of the auditory brainstem response on the 7th day of hospitalization of a 75‐year‐old woman with Bickerstaff's brainstem encephalitis, revealing 2.36 ms in the interval of I--III wave, 1.95 ms in III--V wave, 4.31 ms in I--V wave on the left, and 4.46 ms in I--V wave on the right.](AMS2-7-e517-g001){#ams2517-fig-0001}

Discussion {#ams2517-sec-0006}
==========

We have described a case of a patient with BBE who gradually experienced consciousness disorder but recovered completely after deep coma.

The patient was initially diagnosed with brainstem dysfunction at the upper part of the brainstem, including the midbrain, based on her symptoms of bilateral pupil dilation, loss of light reflex, and other neurological examinations. There were no significant findings in the MRI, EEG, or CSF examinations. Table [1](#ams2517-tbl-0001){ref-type="table"} shows the differential diagnoses of consciousness impairment that physicians find difficult to diagnose in the acute phase.[^1^](#ams2517-bib-0001){ref-type="ref"} We also analyzed anti‐GQ1b antibody levels for diagnosing BBE in this patient.[^2^](#ams2517-bib-0002){ref-type="ref"} Finally, we established a diagnosis of BBE in our patient.

###### 

Causes of impaired consciousness that can be difficult to diagnose in emergency care

  Pathology                  Disease                                                                               Diagnosis
  -------------------------- ------------------------------------------------------------------------------------- ----------------------------
  Cerebrovascular disorder   Stroke (cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage)            Brain imaging (CT/MRI)
                             Pituitary stroke                                                                      
  Autoimmune disease         Myasthenia gravis                                                                     Serology
                             Multiple sclerosis, neuromyelitis optica                                              
                             Behçet disease, Sweet syndrome                                                        
                             Acute disseminated encephalomyelitis                                                  Oligoclonal band in CSF
                             Anti‐GQ1b antibody syndrome (GBS, MFS, BBE)                                           Serology (GQ1b‐IgG or IgA)
                             Autoimmune encephalitis (anti‐NMDA receptor encephalitis, Hashimoto encephalopathy)   Serology
  Infection                  Poliomyelitis                                                                         Virology (PCR)
                             Viral encephalitis                                                                    Virology (PCR)
  Trauma                     Diffuse axon injury                                                                   Brain imaging (MRI)
  Tumor                      Oncology of the brain                                                                 Brain imaging (CT/MRI)
                             Paraneoplastic neurological syndrome                                                  Serology
  Dural disease              Hypertrophic pachymeningitis                                                          Enhanced MRI
  Myelitis                   Acute transverse spondylitis                                                          CSF test, spinal MRI
  Metabolic disease          Trace element deficiency (Wernicke's encephalopathy, carnitine deficiency)            Serology
  Others                     Vasculitis                                                                            Serology
                             Non‐convulsive status epilepticus                                                     EEG
                             Toxic (e.g. botulinum toxin, drug addiction)                                          Serology, urinalysis

BBE, Bickerstaff's brainstem encephalitis; CSF, cerebrospinal fluid; CT, computed tomography; EEG, electroencephalography; GBS, Guillain‐Barré syndrome; Ig, immunoglobulin; MFS, Miller‐Fisher syndrome; MRI, magnetic resonance imaging; NMDA, N‐methyl‐D‐aspartic acid; PCR, polymerase chain reaction.
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Bickerstaff's brainstem encephalitis is an autoimmune disease with the primary lesion in the brainstem. It is believed to be triggered by some type of preinfection, and IgG‐type GQ1b antibodies are detected in the majority of cases. Symptoms are primarily characterized by oculomotor disorders, ataxia, and impaired consciousness. Approximately 20% of cases require ventilator management.[^2^](#ams2517-bib-0002){ref-type="ref"}, [^3^](#ams2517-bib-0003){ref-type="ref"} Table [2](#ams2517-tbl-0002){ref-type="table"} shows the diagnostic criteria for BBE. Bickerstaff's brainstem encephalitis is a rare disease; almost 100 cases are reported every year in Japan, with 120 million habitants.[^4^](#ams2517-bib-0004){ref-type="ref"} It is considered a variant of GBS and these are related conditions that form a continuous range. Miller‐Fisher syndrome is also a variant of GBS and characterized by acute onset of external ophthalmoplegia, cerebellar ataxia, and the loss of tendon reflexes.

###### 

Diagnostic criteria for Bickerstaff's brainstem encephalitis

  "Defined" Bickerstaff's brainstem encephalitis must meet the requirements of (1), (2), and (4).
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  "Probable" Bickerstaff's brainstem encephalitis must meet the requirements of (1) and (4) or (2), (3), and (4).
  \(1\) Acute progressive external ophthalmoplegia,[^†^](#ams2517-note-0004){ref-type="fn"} ataxia, and impaired conscious level by 4 weeks, followed by spontaneous recovery within 12 weeks after onset.
  \(2\) Positive for serum IgG anti‐GQ1b antibodies.
  \(3\) Incomplete agreement on (1) because of one or more of the following reasons:
  --It is impossible to evaluate ataxia because of severe limb weakness or consciousness disturbance.
  --Unconfirmed recovery of symptoms.
  --Remarkable laterality of external ophthalmoplegia.
  --Long tract sign (hemisensory disturbance, pyramidal sign, or spasticity) instead of impaired level of consciousness.
  \(4\) Other conditions are excluded in laboratory and imaging tests. The excluded conditions are Wernicke's encephalopathy, cerebrovascular disorder, multiple sclerosis, neuromyelitis optica, neuro‐Behçet disease, neuro‐Sweet disease, pituitary apoplexy, viral brainstem encephalitis, myasthenia gravis, brainstem tumor, vasculitis, botulism, Hashimoto encephalopathy.

Ig, immunoglobulin.

Lateral symmetry is the rule, but mild laterality is also permitted. Features other than the incomplete item(s) must meet (1).
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The criteria do not include electrophysiological examinations such as EEG, ABR, or somatosensory evoked potential. Auditory brainstem response is presumed to reflect the activation from the cochlea to the midbrain and can detect small lesions especially in the pons.[^5^](#ams2517-bib-0005){ref-type="ref"} This patient was suspected to have brainstem lesions based on neurological examinations and was finally diagnosed with BBE. In fact, the ABR did not show prolonged interval of latency between I and V wave. There were differences between ABR findings and neurological examinations. Some studies have described the characteristics of ABR for patients with BBE. Ogawara *et al*.[^6^](#ams2517-bib-0006){ref-type="ref"} reported that ABR did not reveal prolonged interval of latency between I and V wave, and the low potential in their study patient with BBE and that of our patient were similar. We built a hypothesis that neural cells with an epitope of anti‐GQ1b antibody were damaged, but neural cells without an epitope of anti‐GQ1b antibody had normal nerve conduction.[^7^](#ams2517-bib-0007){ref-type="ref"} Bickerstaff's brainstem encephalitis would not affect the latency of ABR because of several neural cells with normal nerve conduction. However, the potentials of ABR are decreased because the number of normal neural cells decreases. The discrepancy between ABR findings and neurological examinations could be useful for identifying BBE.

Conclusion {#ams2517-sec-0007}
==========

It is possible that emergency physicians could diagnose a patient with BBE as an unknown cause of consciousness disturbance. Neurological examinations are important to detect lesions and suspect BBE. It is also necessary to analyze serum IgG anti‐GQ1b antibodies to diagnose BBE. Auditory brainstem response would be helpful in detecting lesions and predicting functional recovery.
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